| 000 | 01670 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513072805.0 | ||
| 264 | 0 | _c19930809 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.37.6.1238 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreen, M | |
| 245 | 0 | 0 |
_aConstitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJun 1993 |
||
| 300 |
_a1238-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aDNA Probes |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNovobiocin _xpharmacology |
| 650 | 0 | 4 |
_aPenicillins _xpharmacology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 650 | 0 | 4 | _abeta-Lactams |
| 700 | 1 | _aBinczewski, B | |
| 700 | 1 | _aPasculle, A W | |
| 700 | 1 | _aEdmund, M | |
| 700 | 1 | _aBarbadora, K | |
| 700 | 1 | _aKusne, S | |
| 700 | 1 | _aShlaes, D M | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 37 _gno. 6 _gp. 1238-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.37.6.1238 _zAvailable from publisher's website |
| 999 |
_c8328051 _d8328051 |
||